Search

everythinglearnresearchcommunity

for

Search:↓

Oral minoxidil effectively improves hair regrowth in cancer survivors with late alopecia.

Early detection and multidisciplinary management of skin and mouth side effects from breast cancer treatments improve patient outcomes.

DHL-HisZnNa may help reduce hair loss from chemotherapy, but more research is needed.

Personalized hair care strategies are needed for Black cancer patients to prevent hair loss during chemotherapy.

Non-laser devices show promise in treating hair issues, but more research is needed.

Scalp cooling effectively prevents chemotherapy-induced hair loss but requires better pain management.

Polyphenols in plant foods help prevent diseases and have potential uses in food, cosmetics, and more.

Photobiomodulation therapy helps manage cancer treatment side effects but needs more research for optimization.

Hair follicle studies suggest that maintaining telomere length could help treat hair loss and graying, but it's uncertain if mouse results apply to humans.

The new chemotherapy combination for advanced lung cancer showed a 35.7% response rate but caused significant side effects.

Early baldness in men may indicate risks for obesity, metabolic syndrome, insulin resistance, and heart disease, similar to women with PCOS. Alopecia areata is often linked with autoimmune diseases and mental health issues. Certain hair disorders are due to genetic issues, and chemotherapy can cause hair loss through specific biological pathways. Iron deficiency's link to hair loss is still disputed.

New therapies targeting skin neuroimmune interactions could treat neuropathic pain.

The drug combination was safe and showed promise in treating advanced tumors.

Doctors should actively prevent and treat skin side effects in cancer patients to keep them on the best medication and reduce discomfort.

Preventing and managing skin issues from cancer treatment is crucial, especially in high UV areas like Australia and New Zealand.

Consult an oncologist before using supplements for hair loss during breast cancer treatment.

Docetaxel, a chemotherapy drug, was reported to cause psoriasis in a patient for the first time.

XMU-MP-1 stops cell growth in a human mini-organ and reduces the effectiveness of the chemotherapy drug paclitaxel.

The treatments for fungal nail infection, hair loss in men, benign nail tumor, and chemotherapy-associated nail bed inflammation are effective and safe.

ALRN-6924 can protect hair follicles from chemotherapy damage by temporarily stopping cell division.

Cryotherapy helps reduce chemotherapy side effects but needs more research for best use.

The document concludes that systemic therapy is becoming more important in treating head and neck cancer, with new treatments showing promise.

Capecitabine is as effective as intravenous treatments with fewer side effects, but requires careful management of Hand-foot syndrome and patient education.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

African plants may help treat cancer by boosting immunity and protecting cells.

PLD is an effective and safer alternative for treating breast cancer.

Aromatase inhibitor therapy for breast cancer increases the risk of hair loss and thinning.

A child on life support experienced rapid hair loss due to severe illness affecting hair growth.

The combination of high-dose toremifene and capecitabine was effective for advanced recurrent breast cancer.

Chrysin makes docetaxel more effective and reduces its side effects in lung cancer treatment.